Elderly Medical Patients Treated with Prophylactic Dosages of Enoxaparin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elderly Medical Patients Treated with Prophylactic Dosages of Enoxaparin

Published:2007 Issue:1 Volume:24 Page:63-71
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs & Aging

Author:

Mahe Isabelle,Gouin-Thibault Isabelle,Drouet Ludovic,Simoneau Guy,Di??Castillo Heidi,Siguret Virginie,Bergmann Jean-Fran??ois,Pautas Eric

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Reference21 articles.

1. A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

2. Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

3. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

4. Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency

5. How and When to Monitor a Patient Treated with Low Molecular Weight Heparin

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study;Journal of Thrombosis and Haemostasis;2024-07

2. Glass bead-activated clotting time (gb-ACT) for monitoring the anticoagulation effects in elderly patients with high risk of venous thromboembolism (VTE);Expert Opinion on Drug Safety;2024-05-20

3. Monitoring anti‐Xa levels in elderly medical patients undergoing thromboprophylaxis: A prospective cohort study;Geriatrics & Gerontology International;2024-05-05

4. Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial;BMC Medicine;2024-04-23

5. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?;The Pharmacogenomics Journal;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3